Application no. and date | 17731337.6 (espacenet) (Federated) (European Patent Register), 20170524 | Patent/reg. no. and date | DK/EP 3464306, 20240327 | Publication date | 20190410 | Priority no. and date | US 201662340953 P, 20160524, US 201662357134 P, 20160630 | EP pub. no. and date |
EP 3464306 20190410 | Effective date | | Applicant/owner | Sarepta Therapeutics, Inc., 215 First Street
Cambridge, MA 02142, US | Applicant ref. no. | 1697844 | Inventor | CAI, Bao, c/o Sarepta Therapeutics, Inc. 215 First Street
Cambridge MA 02142, US, MARTINI, Mitchell, c/o Sarepta Therapeutics, Inc. 215 First Street
Cambridge MA 02142, US, SHIMABUKU,Ross, c/o Sarepta Therapeutics, Inc. 215 First Street
Cambridge MA 02142, US, THOMAS, Katie, c/o Sarepta Therapeutics, Inc. 215 First Street
Cambridge MA 02142, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61P 21/00 (2006.01) , C07F 9/6558 (2006.01) , C07F 9/6561 (2006.01) | Title | FREMGANGSMÅDER TIL FREMSTILLING AF PHOSPHORODIAMIDAT-MORPHOLINO-OLIGOMERER | Int. application no. | US2017034284 | Int. publication no. | WO2017205513 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|